Market size, growth to 2033 and clinical trials, side by side.
The US is the bigger Dietary Supplements market: $129.4 Bn against $24.8 Bn in 2023, about 5.2 times as large.
China grows faster: 7.7% a year, against 4.2%. The gap still grows from $104.6 Bn to $143.2 Bn by 2033.
Clinical research: 1,043 active trials in the US, 271 in China.
| Measure | ||
|---|---|---|
| Market size, 2023 | $129.4 Bn | $24.8 Bn |
| Market size, 2033 projected | $195.2 Bn | $52 Bn |
| Growth a year (CAGR) | 4.2% | 7.7% |
| Money added, 2023–2033 | $65.8 Bn | $27.2 Bn |
| Share of the world market | 42% | 8% |
| Size rank of 24 countries | #1 | #2 |
| Market per person, 2023 | $378 | $18 |
| Active clinical trials | 1,043 | 271 |
| Full report | US report | China report |
US China · values between 2023 and 2033 are projected from the 2023 size and the CAGR.
The US is the bigger Dietary Supplements market: $129.4 Bn against $24.8 Bn in 2023, about 5.2 times as large.
China grows faster: 7.7% a year, against 4.2%. The gap still grows from $104.6 Bn to $143.2 Bn by 2033.
Sources: market size and growth: Acuitas Health Analytics research (2023 base year, forecasts to 2033). Trials: ClinicalTrials.gov (fetched 10 Nov 2026); found by search words, so counts are a guide. Population: World Bank.